Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_provenance.
- NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_assertion description "[ERBB2 overexpression in estrogen receptor (ER)-positive breast cancer cells such as BT474 (BT) cells has been found to confer resistance to tamoxifen, and suppression of ERBB2 improves the antiproliferative effects of tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_provenance.
- NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_assertion evidence source_evidence_literature NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_provenance.
- NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_assertion SIO_000772 18768663 NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_provenance.
- NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_assertion wasDerivedFrom befree-2016 NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_provenance.
- NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_assertion wasGeneratedBy ECO_0000203 NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_provenance.
- befree-2016 importedOn "2016-02-19" NP691356.RAOTCQhbcVvMuFSzITfPZz8yG7Qmp-Ti_A6Q-lDCIQcdo130_provenance.